Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

Document › Details

Der Brutkasten [Redaktion]. (3/31/21). "News: Grazer Biotech-Startup erhält 400.000 Euro Pre-Seed-Investment. Celeris Therapeutics will mit seiner Plattform ermöglichen, dass bessere Medikamente schneller auf den Markt kommen - und konnte damit internati

	Organisation	Celeris Therapeutics GmbH
	Group	Celeris Therapeutics (CelerixTx) (Group)
	Organisation 2	R42 Group (US)
	Group	i&i Biotech Fund (LU)
	Product	Celeris One™ platform
	Product 2	venture capital
	Index term	Celeris Therapeutics–SEVERAL: investment, 202103 pre-seed financing round €400k from R42 Group + Longevitytech.fund
	Index term 2	Celeris Therapeutics–Longevitytech.fund: investment, 202103 pre-seed financing round totalling €400k incl investor Longevitytech.fund
	Person	Trummer, Christopher (Celeris Therapeutics 202202 CEO + Co-Founder)
	Person 2	Hohenberger, Jakob (Celeris Therapeutics 202202 CFO/COO + Co-Founder)

Original document
accessed by [iito] on 2022-03-04

Record changed: 2022-03-10

More documents for Celeris Therapeutics (CelerixTx) (Group)

[1] Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA....
[2] Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA....
[3] Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA....
[4] Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts"....
[5] Celeris Therapeutics GmbH. (11/29/21). "Press Release: Celeris Therapeutics, Inc., Pioneering AI-driven Degrader Discovery, Appoints Nick DeHaan as VP, Head of Partnering". Menlo Park, CA....
[6] Celeris Therapeutics GmbH. (11/1/21). "Press Release: Celeris Therapeutics, the Pioneer in AI-driven Degrader Design, Builds Laboratories in Austria". Graz....
[7] Celeris Therapeutics GmbH. (8/27/21). "Press Release: Celeris Therapeutics Welcomes Life Sciences and Technology Thought Leader Ian Marks as a Non-Executive Director". Menlo Park, CA....
[8] Der Brutkasten [Redaktion]. (5/3/21). "News: Celeris – 600.000 Euro für Grazer Startup, das Parkinson, Alzheimer und Krebs heilen will"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

» top